arrow left
arrow right
  • Stephens -v- Monsanto Company, et al Print Product Liability Unlimited  document preview
  • Stephens -v- Monsanto Company, et al Print Product Liability Unlimited  document preview
  • Stephens -v- Monsanto Company, et al Print Product Liability Unlimited  document preview
  • Stephens -v- Monsanto Company, et al Print Product Liability Unlimited  document preview
						
                                

Preview

‘ i fl'flifllliflfliflflflflfl”m"i k, \ \ Joe G. Hollingsworth (appearance pro hac vice) Eric G. Lasker (appearance pro hac vice) AWN Martin C. Calhoun (appearance pro hac vice) HOLLINGSWORTHrLLP 1350 I Street, N.W. FILED ALAMEDA COUNTY Washington, DC 20005 Telephone: (202) 898-5800 - - Novz mmm- 2020 . Facsimile: (202) 682-1639 jhollingsworth@hollingsworthllp.com CLERK 0F elasker@hollingsworthllp. com By mcalhoun@hollingsworthllp. com Deputy \OOOQOU‘ Sandra A. Edwards (State Bar No. 154578) WINSTON & STRAWN LLP 101 California Street, 34th Floor San Francisco, CA 941 l 1-5840 Telephone: (415) 591-1000 Facsimile: (415) 591-1400 10 sedwards@winston.com 1‘1 Attomeysfor Defendant MONSANTO COMPANY 12 SUPERIOR COURT OF THE STATE OF CALIFORNIA 13 14 FOR THE COUNTY OF ALAMEDA <3Q 01 15 COORDINATION PROCEEDING SPECIAL VSB 21M 80:11“? hm- m3 TITLE (RULE 3.550) 16 ASSIGNED FOR ALL PURPOSES TO <\\ w 0’3 ROUNDUP PRODUCT CASES JUDGE WINIFRED SMITH (9:; 17 DEPARTMENT 2| (Tr: fly ,_ L: .18 THIS DOCUMENT RELATEs To; DEFENDANT MONSANTO COMPANY’ S SUPPLEMENTAL OPPOSITION TO 19 v. Monsanto Company, e! Donnetta Stephens PLAINTIFF DONNETTA STEPHENS’ al. County of San Francisco, Case (Super. Ct. MOTION FOR TRIAL 20 No. CGC-20-585764) . PREFERENCE 21 '22 R-22] 13248 Reservation ID: Hearing'Date: December 9, 2020 23 Time: 9:00 am _ Place: Department 21. 24 25 26 27 28 DEFENDANT MONSANTo Co.’s Supp. OPP. To PLAINTIFF DONNErrA STEPHENs’ MOTION FOR TRIAL PREFERENCE ". m i i I. INTRODUCTION ~ Despite an opportunity to suppiement her medicél records‘, Plaintiff Donnetta Stephens has Awm not met her burden of éstablishing that she is entitled to a preferential trial setting under California Code of Civil Procedure (“CCP”) § 36(a) in this coordinated proceeding. First, Plaintiff‘s supplemental records confirm that she was last treated for her marginal zone B-cell lymphoma (“MZL”) 14 months ago, and she has been in complete remission since at least Cmflau‘ January 2020. While her supplemental brief claims Plainfiff‘s health has taken a “downward tum,” her records show her vertigo and neuropathy are chronic conditions that pre-datc her MZL diagnosis—indeed, her chronic benign vertigo dates back to at least 2013. As in her motion, l0 Plaintiff lists a myriad of other medical conditions she has experienced in the last several years, but 1] they arc either unsupported by the medical records, resolved medical problems, common to 12 individuals of advanced age, and/or effectively managed by Plaintifi‘s physicians with medication or 13 monitoring. Her prognosis remains “very good,” and her MZL is “not at high risk of recurrence 14 within the next 120 days,” as set forth in ’the accompanying. supplemental declaration of Dr. Kenneth 15 Miller (“Supp. Miller Decl.”). 16 Second, Plaintiff has failed to demonstrate that her individual interests outweigh the interests 17 of all other parties and the efficient management of this coordinated proceeding, which this Court’s 18 November 12, 2020 Order expressly confirmed may be considered. Given the current posture of this l9 coordinated proceeding, Plaintiff cannot obtain trial preference without significantly impairing the 20 interests of other plaintiffs and disrupting the centralized and efficient management required by CCP 21 § 404 and the California Rulés of Court for coordination 6f compléx actions (CRC 3.500 et seq.). 22H As’set forth in Monsarito’s original Opposition, if the parties are unable to reach a resolution ' 23 fo’llowing the Court-ordered settlement process, Plaintiff can re-fil; the motion at a later date. 24 II. ARGUMENT 25 A. Plaintiffs Supplementéd Medical Records Show No Wbrsening Conditions Reguiring Trial Preference to Prevent Prejudice. 26 27 Monsanto's Opposition and supporting expert declaration explained that Plaintifi‘s medical 28 records do not support the conclusion that her health Will prevent her from meaningfully ‘ . 1 DEFENDANT MON SANTO Co.’s SUPP. OPP. To PLAINnFF DONNE'ITA STEPHENS’ MOTION FOR TRIAL PREFERENCE